Home Adhesives Coatings Polymers Cosmetics Compliance AI
OnlyTRAININGS | Where Expertise Matters Most

Learn It Here.
Master It Everywhere.

Expert insights that go beyond the blog, written for professionals who want real industry knowledge.

Agentic AI for Chemical R&D: Do You Really Need a Fully Robotic Laboratory to Start?
Agentic AI for Chemical R&D: Do You Really Need a Fully Robotic Laboratory to Start?

The phrase “self-driving laboratory” tends to create a very specific image: robotic arms moving samples between instruments, automated liquid handlers preparing experiments, analytical equipment feeding results directly into software and artificial intelligence deciding what should happen next. Those systems are real, and their capabilities are advancing quickly, but they can also create the misleading impression that autonomous R&D is relevant only to organizations willing to build an expensive robotic facility from scratch.

For many chemical companies, that is not the most practical way to think about agentic R&D.

A laboratory can begin moving toward autonomous experimentation long before every physical task is automated. The more important change is whether experimental results can influence the next decision in a structured, repeatable way. If an optimization system can evaluate recent formulation data, identify which experiment would be most informative and recommend the next candidate, the laboratory has already introduced an element of autonomous decision-making even if scientists still prepare and test the sample manually.

This distinction matters because it creates a realistic migration path for existing R&D laboratories rather than forcing companies to choose between conventional experimentation and a fully robotic future.

Laboratory Automation and Laboratory Autonomy Are Not the Same Thing

Chemical laboratories have used automation for many years. Automated titrators, liquid handlers, robotic sample preparation, high-throughput screening equipment, autosamplers and automated analytical instruments are already familiar across pharmaceutical, polymer, coatings, catalyst and formulation research.

Most of these systems, however, follow a predefined sequence.

A scientist may create a matrix of 48 formulations, program the liquid handler to prepare them and allow an analytical instrument to measure each sample automatically. This improves throughput and reduces repetitive work, but the experimental campaign was still designed in advance. The equipment executes instructions; it does not decide whether the next planned experiment remains useful after seeing the first ten results.

Autonomous experimentation introduces a feedback mechanism. Results from one group of experiments can alter what is tested next. The system may decide that one region of the formulation space deserves more attention, that another is clearly unproductive or that an unexpected result should be investigated before continuing.

This adaptive decision layer is what begins to turn automation into a self-driving workflow.

For existing chemical R&D teams, that layer can be introduced gradually. A formulation scientist may still weigh raw materials manually while a Bayesian optimization model recommends the next composition. Results may still be transferred from an instrument by a researcher rather than through a direct software connection. The workflow is not fully autonomous, but the experimental strategy is already becoming data-driven and adaptive.

The Best Starting Point Is Usually the R&D Bottleneck, Not the Robot

Every laboratory has a different constraint, and automation creates little value when it is applied to the wrong problem.

In one formulation laboratory, scientists may spend hours preparing repetitive blends while analytical testing is relatively fast. In another, sample preparation may take minutes but chromatography, microscopy or mechanical testing creates a queue lasting several days. Some teams can run large numbers of experiments but struggle to decide which combination should be tested next because the design space has become too large.

This is why a sensible agentic R&D strategy starts by mapping the actual experimental cycle rather than selecting technology first.

A typical development loop may involve formulation or synthesis, processing, sample conditioning, measurement, data interpretation, decision-making and another experiment. The R&D team can then identify where unnecessary delay, variability or repetitive work is occurring.

If the largest problem is deciding what to test, adaptive experimental design or Bayesian optimization may create more value than physical automation. If formulation preparation is the major bottleneck, automated dispensing and mixing may be the better first investment. If characterization produces large image or spectral datasets that researchers struggle to interpret consistently, artificial intelligence may initially be more useful in analytical interpretation than in experiment execution.

Recent autonomous-laboratory research increasingly reflects this wider view. In July 2026, researchers reported artificial-intelligence agents capable of automating parts of materials-characterization workflows using vision-language models, showing that autonomy can be introduced within experimental interpretation and instrumentation rather than only through robotic sample handling. (nature.com)

For industrial R&D, this is an important point because it allows implementation to follow the economics of the existing laboratory rather than an idealized self-driving-lab architecture.

Agentic AI Can Coordinate Tools That Previously Operated Separately

The growing interest in agentic AI is partly driven by its potential to connect systems that were historically used independently.

A conventional machine-learning model might predict viscosity, glass-transition temperature or corrosion resistance from a set of formulation variables. An agentic system can potentially go further by deciding which model or data source should be used, interpreting the result and determining which action should follow.

In a chemical R&D environment, an agent might interact with a historical formulation database, property-prediction model, experimental-design algorithm, laboratory scheduler, analytical repository and reporting system. It may retrieve previous experiments, check which variables have already been explored, identify missing information and generate a recommendation for the next experiment.

This becomes more sophisticated when several specialized agents are used. One agent could focus on experimental planning, another on data quality, another on laboratory scheduling and another on scientific review. Instead of relying on one large model to perform every task, the system can divide work across different functions.

Current research is beginning to explore exactly this type of architecture. Self-driving laboratory systems reported in 2026 include both centrally managed artificial-intelligence frameworks and multi-agent designs in which specialized software components coordinate different parts of the experimental workflow. (nature.com)

An August 2026 Chemical Science paper also examined multi-task scheduling for self-driving laboratories, addressing the practical problem of coordinating several experiments and scientific objectives when instruments, timing and resources are limited. (doi.org)

This is where agentic AI becomes more relevant to industrial laboratories. The benefit may not come from one model making a brilliant scientific prediction. It may come from coordinating multiple small decisions that currently require researchers to move manually between spreadsheets, instruments, databases and project-management systems.

Natural-Language Interfaces Could Simplify Laboratory Interaction, but They Also Introduce Risk

Another rapidly developing area is the use of natural language to interact with laboratory systems.

Rather than programming every instrument command manually, researchers may eventually be able to describe an experimental objective in ordinary technical language and allow an artificial-intelligence system to translate that instruction into a structured workflow.

Research systems are already demonstrating parts of this capability. AutoLabs, for example, has shown a multi-agent approach in which natural-language experimental instructions are translated into protocols for high-throughput liquid handling while incorporating a degree of self-correction. (nature.com)

The potential is significant because it could reduce the programming burden associated with laboratory automation. A polymer scientist should not necessarily need to become a robotics engineer simply to automate an experimental sequence.

The difficulty is that chemical laboratories operate under physical and safety constraints that conversational software cannot be allowed to ignore.

A language model may generate an instruction that appears logically coherent while violating a temperature limit, pressure restriction, solvent-compatibility rule or chemical-safety requirement. An agent could also recommend an experimental combination that falls outside a validated equipment range or introduces an unexpected exothermic risk.

Natural-language control therefore needs to sit inside a much more disciplined architecture. Permitted actions, equipment limits, chemical incompatibilities, operating windows and approval rules need to be encoded independently of the language model.

The convenience of natural-language interaction should never become permission for unrestricted experimental control.

Safety Becomes More Important as the System Gains Autonomy

Autonomous laboratories introduce a different safety problem from conventional automation because the system may generate actions that were not explicitly programmed by a researcher in advance.

A predefined liquid-handling method can be validated before use. An adaptive system may choose a different composition, temperature or experimental sequence based on incoming data.

That creates the need for experimental guardrails.

A study published in August 2026 specifically examined robotic safety in self-driving laboratories and noted that increasingly complex autonomous facilities combine multiple robotic platforms while safety practices are not always incorporated systematically during development. (sciencedirect.com)

For chemical R&D, robotic movement is only one part of the concern. The system must also respect chemical incompatibility, maximum safe concentrations, pressure limits, thermal runaway risks, ventilation requirements, flammability conditions, waste-handling rules and equipment-specific operating constraints.

This is one of the clearest examples of why domain expertise remains essential in agentic R&D.

An artificial-intelligence system can search an experimental space efficiently, but chemists and engineers must define where that search is allowed to occur.

The more autonomy the system receives, the more important those boundaries become.

Human-in-the-Loop Systems May Be the Best Industrial Starting Point

Full autonomy attracts attention because it suggests continuous experimentation without constant human intervention. In practice, many industrial laboratories may gain more value from partial autonomy.

A human-in-the-loop architecture allows artificial intelligence to handle repetitive data analysis, experimental ranking and routine recommendations while leaving higher-consequence decisions with scientists.

For example, an optimization model might recommend the next six formulations but require researcher approval before they are prepared. The system might automatically reject candidates that exceed predefined viscosity, cost or safety constraints. It could identify unusual analytical results and request additional testing rather than treating them as reliable data immediately.

This staged approach gives teams an opportunity to learn how the system behaves before expanding its authority.

It also fits more easily into existing laboratories because instruments do not all need to be replaced or directly connected at once. Scientists can continue using familiar equipment while selected parts of the decision loop become more automated.

The broader industrial direction supports this interpretation. Recent discussion in Nature Synthesis places autonomous laboratories within a larger digital-chemistry and industrial-optimization environment rather than treating them simply as isolated robotic demonstrations. (nature.com)

For many companies, the most realistic future may therefore be a mixed laboratory in which some activities are fully automated, others are AI-assisted and a smaller number remain deliberately human-controlled.

Existing R&D Data May Be a Bigger Barrier Than Hardware

Companies considering autonomous experimentation often focus first on robotics, but the condition of their historical R&D data may create the larger obstacle.

Formulation data are frequently scattered across spreadsheets, electronic laboratory notebooks, instrument computers, PDFs, emails and personal folders. Different scientists use different names for the same raw material. Batch information may be missing. Failed experiments are sometimes barely recorded. Processing conditions may change without being documented in a consistent field.

This becomes a serious problem when artificial intelligence is expected to learn from those records.

A scientist may remember that “Sample 47” failed because the raw material had absorbed moisture or because the mixing sequence was changed. A model sees only the values that were recorded.

Autonomous R&D therefore requires much stronger experimental provenance than many conventional laboratories currently maintain.

Useful records may need to include raw-material identity, supplier grade, batch information, processing sequence, equipment settings, temperature history, environmental conditions, analytical method and reasons for experimental failure.

That data work is not as visually impressive as installing robotics, but it is often the foundation on which autonomous optimization depends.

An organization with sophisticated robots and inconsistent experimental data may simply automate unreliable decisions faster.

Formulation R&D Offers a Practical Entry Point

Formulation development is one of the more accessible environments for staged autonomous experimentation because many projects already involve structured changes in composition and measurable performance responses.

An adhesive laboratory may vary resin ratio, filler loading, catalyst concentration and cure conditions. A coatings laboratory may adjust binder composition, pigment level, crosslinker, dispersant and additives. A polymer-compounding team may change polymer ratio, compatibilizer, filler and processing temperature. A cosmetic formulator may vary surfactant systems, oil phase, rheology modifiers and actives.

These variables can be organized into experimental design spaces without immediately automating every laboratory operation.

A first stage could involve structured historical data and Bayesian optimization, with scientists manually executing recommended formulations. A second stage might introduce automated dispensing or mixing for the highest-volume workflows. A third stage could connect rapid analytical feedback so that the optimization model receives results more quickly.

Only after those components are reliable would continuous closed-loop operation become necessary.

This staged development path is likely to be more practical for established industrial laboratories than attempting to build a fully autonomous facility in one step.

It also allows the R&D team to demonstrate value at each stage rather than committing to a large automation programme before understanding where autonomy actually improves development.

The Purpose Is Not to Remove Scientists From R&D

One of the least useful ways to frame agentic AI is as a replacement for laboratory scientists.

The more valuable opportunity is to change how scientific time is used.

Researchers currently spend large amounts of time organizing experimental matrices, transferring data, checking instrument outputs, comparing formulations and deciding which candidate should be tested next. Some of these tasks are scientifically important, but many are repetitive.

If artificial intelligence can handle routine experimental ranking, detect obvious constraint violations, organize incoming data and suggest the next high-value experiment, scientists can spend more time interpreting unexpected behavior, examining mechanisms and deciding whether the optimization objective itself still makes sense.

This becomes particularly important as experimental throughput increases.

A highly automated laboratory can generate results faster than a small scientific team can interpret them manually. Better decision support may therefore become necessary simply to keep human expertise focused on the experiments that matter most.

The role of the scientist does not disappear. It shifts toward defining meaningful objectives, establishing boundaries, interpreting ambiguity and recognizing when the model is asking the wrong question.

A Practical Roadmap Toward Agentic Chemical R&D

Organizations interested in agentic R&D do not need to begin by designing a self-driving laboratory.

A more practical first step is to identify one development workflow with repeatable experiments, structured variables and measurable outputs. That workflow should also contain a genuine decision bottleneck where adaptive experimental planning could create value.

The team can then organize historical data, define the experimental variables, establish realistic operating limits and identify which responses should guide optimization.

Algorithm-guided experimental selection can be introduced before physical automation. Scientists can execute the recommended experiments manually and review whether the system is producing useful decisions.

Once that decision layer is trusted, automation can be added where it removes genuine delays or variability. Sample preparation, dispensing, mixing, curing, conditioning or analytical measurements can each be connected gradually.

The experimental feedback loop can then become tighter as more steps are integrated.

This sequence is usually easier to manage because each new level of autonomy is justified by an existing need rather than by the desire to build a technologically impressive laboratory.

Agentic AI Is Really About Connecting the Experimental Loop

The most important change in agentic chemical R&D is not the appearance of robotics. It is the connection between experimental objectives, data, models, laboratory actions and subsequent decisions.

Current work in chemistry and materials research is already bringing these elements together through AI agents, Bayesian optimization, automated characterization, laboratory scheduling and closed-loop experimentation. (nature.com)

Industrial laboratories do not need to reproduce the most advanced academic self-driving facilities to benefit from the same principles. A coatings, adhesives, polymer, personal-care or specialty-chemicals laboratory can begin with a much narrower workflow and progressively automate only the parts that produce measurable value.

For R&D managers, the more useful question is therefore not whether the organization is ready for a fully robotic laboratory. It is whether the current experimental process can begin learning more systematically from each result and using that information to make the next decision better.

That is the point at which AI moves from being another tool used around R&D to becoming part of the experimental operating system itself.

Moving From AI-Assisted R&D Toward Autonomous Experimentation

The OnlyTRAININGS advanced session Agentic AI in Chemical R&D: Self-Driving Labs & Formulation Optimization is designed for chemical and materials professionals who want to understand how this transition can be implemented in realistic R&D environments.

The training examines the practical difference between AI assistants and AI agents, Bayesian optimization, active learning, formulation optimization, experimental feedback, laboratory automation, multi-agent workflows, data quality, failed-experiment handling, safety guardrails and human oversight.

Rather than assuming that every participant already operates a robotic laboratory, the session looks at how existing formulation and materials-development workflows can progress from AI-supported decision-making toward increasingly closed-loop and autonomous experimentation.

For teams already using artificial intelligence for literature searching, technical summarization or data analysis, the next opportunity is considerably more interesting: allowing AI to participate in deciding what experiment should happen next, why it should happen and what should be learned from the result.

Explore the Agentic AI in Chemical R&D: Self-Driving Labs & Formulation Optimization training:
https://www.onlytrainings.com/course/agentic-ai-chemical-rd-self-driving-labs-formulation-optimization/

agentic AI, agentic AI chemical R&D, self-driving laboratories, self-driving labs, autonomous experimentation, AI agents for chemistry, artificial intelligence in chemistry, AI in chemical R&D, laboratory automation, chemical laboratory automation, autonomous laboratory, autonomous labs, AI laboratory automation, formulation optimization, AI formulation optimization, Bayesian optimization, Bayesian optimization materials science, Bayesian optimization formulation, active learning, closed-loop optimization, closed-loop experimentation, materials discovery, AI materials discovery, autonomous materials discovery, digital R&D, chemical R&D automation, machine learning chemistry, AI-driven experimentation, autonomous chemical experimentation, robotic laboratory, robotic chemistry, high-throughput experimentation, experimental design AI, multi-objective optimization, multi-agent AI, multi-agent laboratory, formulation development AI, self-driving laboratory chemistry, AI agents materials science, autonomous formulation optimization


Read more →
Bayesian Optimization for Formulation R&D: Why the Next Experiment Matters More Than a Larger Test Matrix
Bayesian Optimization for Formulation R&D: Why the Next Experiment Matters More Than a Larger Test Matrix

Formulation scientists are accustomed to working with incomplete information.

A new adhesive, coating, polymer compound or personal-care formulation may contain five, ten or twenty adjustable variables, while laboratory time allows only a small fraction of the possible combinations to be tested. Development therefore depends on experimental strategy as much as chemical knowledge.

Design of Experiments has helped R&D teams manage this problem for decades. Properly designed factorial, response-surface and mixture experiments can reveal important main effects, interactions and useful operating regions with far fewer runs than uncontrolled trial and error.

Bayesian optimization does not make Design of Experiments obsolete. It addresses a somewhat different problem: what should be tested when the experimental plan is allowed to change after every new result?

That distinction is becoming increasingly relevant as chemical R&D moves toward autonomous experimentation.

Traditional Experimental Designs Are Usually Planned Before the Results Arrive

In a conventional Design of Experiments programme, researchers define factors, ranges, responses and an experimental design before the work begins.

The planned experiments are then carried out, the data are analysed and a model is fitted. Researchers may subsequently design another experiment if refinement is needed.

This approach works extremely well when the objective is understanding factor effects, building interpretable models and exploring a reasonably well-defined experimental region.

The limitation appears when experiments are expensive and the design space is very large.

Suppose a formulation team is optimizing an electrically conductive adhesive. The variables include epoxy-to-hardener ratio, silver loading, particle-size distribution, reactive diluent, accelerator level, dispersant concentration and cure temperature. Responses include viscosity, electrical resistance, lap-shear strength and glass-transition temperature.

The team does not necessarily need a complete statistical map of every possible interaction. It may primarily need to identify a formulation meeting several performance limits with as few experiments as possible.

This is where Bayesian optimization becomes attractive.

Bayesian Optimization Learns While the Experimental Campaign Is Running

Bayesian optimization typically uses a surrogate model to estimate how experimental variables relate to a target response.

More importantly, the model also represents uncertainty.

An acquisition function then decides which experiment is most useful to perform next. Sometimes that means testing a formulation predicted to perform very well. At other times it means testing a poorly understood region because reducing uncertainty there may improve the overall model.

After the result is collected, the surrogate model is updated and another experiment is selected.

The experimental sequence therefore becomes adaptive.

A July 14, 2026 paper in npj Computational Materials introduced a unified Bayesian optimization framework intended to accelerate materials discovery, reflecting the continued expansion of these approaches across complex materials spaces.

Recent work is also showing the value of combining Bayesian optimization with scientific knowledge rather than treating the system as an entirely blind search. An ACS study published in July incorporated researchers' prior knowledge directly into the optimization framework to identify useful materials conditions with fewer experiments.

For industrial formulators, that is particularly important because decades of chemistry knowledge already exist.

Formulation Problems Are Especially Suitable for Adaptive Optimization

Many formulation problems share characteristics that make Bayesian optimization useful.

Experiments may be expensive. The design space is multidimensional. Variables interact. The relationship between composition and performance may be nonlinear. Several responses may conflict with one another.

A polyurethane adhesive might need high strength but low modulus. A thermal interface material may need maximum thermal conductivity while remaining dispensable. A coating could require corrosion resistance, flexibility, adhesion and low volatile-organic-compound content simultaneously.

The optimum therefore rarely lies at the maximum of one response.

Bayesian optimization can be configured for multiple objectives or constraints, allowing researchers to explore trade-offs rather than optimizing a single property in isolation.

Recent materials research is increasingly applying this logic to practical development problems. A study published August 28, 2026 used Bayesian optimization to explore process-structure-property relationships in polyethylene composite films, demonstrating how adaptive optimization can guide materials development across coupled variables.

Bayesian Optimization and DoE Should Not Be Treated as Competitors

One of the least useful discussions in AI-enabled R&D is the claim that machine learning will replace Design of Experiments.

Experienced industrial teams are more likely to benefit from combining the two.

Design of Experiments provides structured exploration, interpretable factor effects and statistically disciplined experimental planning. Bayesian optimization provides adaptive selection of future experiments based on what has already been learned.

A practical workflow might begin with a space-filling or statistically designed initial dataset. Bayesian optimization can then use that data to recommend subsequent experiments.

The first stage gives the model broad information about the system. The second stage concentrates experimental resources where improvement is most promising.

This combination can be particularly valuable when datasets are small, which is common in formulation R&D.

Small Data Changes the AI Strategy

Much discussion about artificial intelligence assumes very large datasets.

Formulation scientists often have the opposite problem.

A project may contain 40 reliable historical experiments, not 40 million. Some formulations were tested for viscosity but not adhesion. Raw-material grades changed during the programme. Processing conditions may not have been recorded consistently.

This makes conventional deep-learning approaches difficult.

Bayesian methods are attractive partly because they can operate in relatively small-data environments while representing uncertainty explicitly.

The model does not need to pretend that it knows everything.

When uncertainty is high, the optimization strategy can deliberately choose experiments that provide additional information.

That is a powerful idea for R&D because the best experiment is not always the formulation predicted to have the highest performance. Sometimes the most valuable experiment is the one that reduces uncertainty enough to improve future decisions.

Failed Experiments Still Contain Information

Traditional project records frequently contain a bias toward successful formulations.

Researchers may document the final candidates carefully while failed batches, unstable samples or unprocessable formulations receive minimal attention.

An autonomous optimization system needs those failures.

A formulation that phase separated immediately provides useful information about the feasible design region. A sample that exceeded the maximum viscosity limit tells the model that certain combinations should be avoided. A cure experiment that produced excessive exotherm may define a safety constraint.

Negative results therefore become part of the model's understanding of the design space.

This requires better data discipline because the reason for failure matters. A formulation that failed chemically is different from an experiment invalidated by an instrument malfunction or weighing error.

The transition to AI-guided formulation therefore depends as much on experimental metadata as on algorithms.

Multi-Objective Optimization Is Where Industrial Value Becomes Clearer

Academic optimization problems are often expressed as finding a maximum or minimum response.

Industrial formulation is rarely that simple.

A commercially useful product may need to meet ten specifications simultaneously while remaining cost-effective and manufacturable.

Instead of asking for the formulation with maximum peel strength, the optimization problem might be defined as:

increase peel strength while keeping viscosity below the dispensing limit, maintaining glass-transition temperature above the requirement, reducing raw-material cost and avoiding cure temperatures incompatible with the customer's process.

The output may not be one perfect formulation.

It may be a Pareto front containing several technically attractive compromises.

The formulator then brings business, manufacturing and application knowledge into the final decision.

This is a good example of how artificial intelligence can augment rather than eliminate human judgement.

Formulation Optimization Becomes Even More Powerful When Connected to Automation

Bayesian optimization can be used without laboratory robotics.

Scientists can manually prepare the experiments recommended by the algorithm and return the measured results.

Once preparation and analytics become automated, however, the optimization loop can run more frequently.

A self-driving laboratory combines this adaptive decision layer with automated execution and measurement. The algorithm recommends the next experiment, laboratory equipment executes it, analytical instruments produce feedback and the model updates its recommendation.

Current self-driving laboratory research increasingly describes precisely this closed-loop relationship between AI, automation and experimentation.

The key point for formulation teams is that Bayesian optimization is useful before the laboratory becomes fully autonomous.

It can be one of the first practical steps toward agentic R&D.

The Question Is Not How Many Experiments AI Can Eliminate

Claims that an optimization algorithm can reduce experiments by a fixed percentage should be treated cautiously.

Performance depends heavily on the problem, data quality, variable selection, constraints, starting dataset and underlying response landscape.

A simple formulation may already be efficiently solved using conventional statistical design. A highly nonlinear system with expensive measurements may benefit substantially from adaptive optimization.

The objective should not be to demonstrate that artificial intelligence uses fewer experiments at any cost.

It should be to increase the information gained from each experiment.

That is a much more useful R&D metric.

Bringing Bayesian Optimization Into Chemical R&D

For formulation teams, the practical questions are often more difficult than the mathematical definition of Bayesian optimization.

Which formulation variables should be included? How should categorical raw-material choices be represented? How should hard constraints be handled? How much initial data are required? Which responses should be optimized simultaneously? How should failed experiments be encoded? When should scientists override the recommendation?

These implementation decisions determine whether the system becomes scientifically useful.

The OnlyTRAININGS advanced session Agentic AI in Chemical R&D: Self-Driving Labs & Formulation Optimization examines Bayesian optimization in this wider experimental context.

The training connects active learning and optimization algorithms with formulation design, experimental feedback, AI agents, laboratory automation, data quality and human oversight so that R&D teams can understand how adaptive optimization fits into real chemical development workflows.

Explore the Agentic AI in Chemical R&D training:
https://www.onlytrainings.com/course/agentic-ai-chemical-rd-self-driving-labs-formulation-optimization/

Bayesian optimization, formulation optimization, AI formulation optimization, Design of Experiments, active learning, multi-objective optimization, materials optimization, AI-driven formulation, experimental design, Bayesian optimization for chemical formulation, Bayesian optimization vs Design of Experiments, AI formulation optimization for chemical R&D, machine learning formulation optimization, Bayesian optimization materials discovery


Read more →
Self-Driving Laboratories in Chemical R&D: How Agentic AI Turns Experiments Into Decisions
Self-Driving Laboratories in Chemical R&D: How Agentic AI Turns Experiments Into Decisions

Artificial intelligence has already entered many chemical R&D departments, but most current use remains relatively passive. Scientists use large language models to search literature, summarize technical information, generate hypotheses, review experimental data or suggest possible formulations. These applications can save time, yet the scientist still decides which experiment should be carried out next.

Self-driving laboratories introduce a fundamentally different model. Instead of using artificial intelligence only before or after an experiment, the AI becomes part of the experimental decision loop. Experimental results are collected, interpreted and used to determine what should be tested next. When the necessary laboratory automation and analytical systems are connected, the next experiment can then be executed and the cycle repeated.

That transition from AI assistance to autonomous experimentation is becoming one of the most important developments in digital chemical research.

A major review published in Nature Reviews Chemistry on July 31, 2026 describes self-driving laboratories as systems combining autonomous experimentation, advanced reactor engineering, robotics and artificial intelligence. The authors note that these platforms have moved beyond narrow automation toward systems capable of proposing, executing and interpreting experiments with increasingly limited human intervention.

For chemical and formulation R&D teams, however, the important question is not whether a laboratory looks futuristic. It is whether the system can make better experimental decisions.

A Self-Driving Laboratory Is More Than Laboratory Automation

Laboratory automation is not new. Liquid handlers, automated reactors, robotic sample preparation, high-throughput screening equipment and automated analytical instruments have been used for years.

What differentiates autonomous experimentation is the feedback loop.

In a traditional automated workflow, the scientist may define 96 formulations in advance. A liquid-handling robot prepares them, instruments measure their properties and the resulting data are returned to the research team. Automation improves throughput, but the experimental plan remains fixed.

In a self-driving workflow, the system may begin with a smaller number of experiments. After those experiments are measured, an optimization algorithm evaluates the results and decides which formulation or processing condition would provide the most valuable new information. That experiment is executed, measured and incorporated into the model before another decision is made.

This is particularly useful when the experimental design space is too large to explore exhaustively.

Consider a coating formulation containing a binder, crosslinker, catalyst, pigment, dispersant and rheology modifier, with cure temperature and film thickness also influencing performance. Even using only five possible levels for eight variables would create 390,625 potential combinations. Running every combination is obviously impossible.

A closed-loop optimization system does not need to test the entire space. Its objective is to identify which small subset of experiments is most informative for reaching the desired performance target.

Agentic AI Adds a Decision Layer

The growing interest in agentic AI is important because autonomous R&D requires more than predictive modelling.

An AI agent can receive a research objective, use available models and tools, interpret results, maintain information about previous experiments and determine what action should occur next.

Recent work in materials science is already moving in this direction. A July 25, 2026 study reported an autonomous large-language-model agent capable of selecting physical equations, generating and running computational code and testing how well theoretical models matched materials data without requiring continuous human intervention. The researchers also identified limitations, reinforcing the need for scientific validation rather than assuming that language-model reasoning alone is reliable.

Another study published July 31 introduced Experiment Automation Agents that use vision-language models to automate complex materials-characterization workflows. This shows that AI agents are beginning to interact not only with text and databases but also with laboratory instrumentation and experimental images.

For chemical R&D, this creates the possibility of an agent that does more than recommend a formulation. It might identify an experimental objective, access previous formulation results, determine which variables remain uncertain, select a new experiment, instruct compatible laboratory equipment, interpret analytical results and decide whether the next experiment should explore a new region or refine the current optimum.

That is a very different capability from asking a chatbot for five formulation suggestions.

Closed-Loop Experimentation Depends on Good Feedback

Every autonomous experiment requires feedback. If the analytical result is slow, unreliable or disconnected from the experimental system, the loop becomes difficult to maintain.

This is why self-driving laboratories depend heavily on analytical automation.

For a polymer formulation, useful feedback might include viscosity, molecular weight, conversion, tensile strength or thermal transition data. A coatings platform could use gloss, contact angle, hardness, adhesion or spectral information. An adhesive platform might measure lap-shear strength, cure behavior, rheology or peel performance.

The property does not always need to be the final commercial performance metric. A fast-to-measure surrogate property can sometimes guide the optimization process before more expensive validation tests are introduced.

Recent work illustrates this increasingly integrated approach. The AI-eChemist Laboratory, published August 6, 2026, combines intelligent decision-making, automated high-throughput experimentation, multimodal characterization and data-driven analysis in a self-driving electrocatalysis platform.

This architecture is relevant far beyond electrocatalysis. The same principle applies whenever formulation preparation, measurement and experimental selection can be linked into a reliable feedback cycle.

The Algorithm Does Not Simply Search for the Highest Number

Industrial formulation rarely involves a single objective.

A coating with maximum hardness may become too brittle. An adhesive with maximum lap-shear strength may have unacceptable viscosity. A polymer compound with maximum thermal conductivity may lose processability. A surfactant system with excellent detergency may create excessive irritation or foam.

Autonomous formulation therefore becomes a multi-objective optimization problem.

The system may need to maximize performance while simultaneously controlling viscosity, cost, cure time, stability, sustainability or processing constraints. Instead of finding one mathematically highest response, it may identify a set of trade-off solutions from which the formulator can choose.

This is one reason Bayesian optimization and active learning are becoming increasingly important in autonomous experimentation. They allow experimental resources to be directed toward regions of the design space where useful improvement or information is most likely.

A unified Bayesian optimization framework for materials discovery published July 14, 2026 reflects the growing interest in these data-efficient search strategies.

Human Knowledge Still Matters

The emergence of self-driving laboratories does not make the formulator irrelevant.

The system still needs scientifically meaningful boundaries. A polymer scientist knows that certain monomer ratios are unrealistic, that a catalyst becomes unstable above a particular temperature or that a viscosity window is necessary for manufacturing. Those constraints should not be rediscovered by wasting experiments.

One important direction in current research is therefore incorporating existing scientific knowledge into optimization algorithms.

A July 2026 ACS study demonstrated a Bayesian optimization approach that explicitly incorporated researcher knowledge about relationships between experimental conditions and target properties. The aim was to reach useful solutions with fewer experiments by combining prior knowledge with data-driven optimization.

This is particularly relevant to experienced industrial R&D groups because they already possess years of formulation knowledge. The opportunity is not to discard that expertise but to encode enough of it that the AI does not begin every development programme as though nothing is known.

Data Quality Becomes More Important as Autonomy Increases

An autonomous laboratory learns from experimental results. Poor data therefore create poor decisions much faster than in a manual laboratory.

Several problems become important: inconsistent raw-material lots, incorrect sample identification, sensor drift, failed experiments, missing measurements, instrument calibration problems and undocumented processing differences.

A human researcher may recognise that a viscosity result looks suspicious because the sample contained visible bubbles. An autonomous system needs a mechanism for detecting or flagging such situations.

Provenance is therefore becoming a major topic in self-driving laboratory design. The 2026 Nature Reviews Chemistryassessment identifies provenance-complete experimentation, scalability and generalizability as central requirements for the next stage of self-driving laboratory development.

For industrial chemical R&D, this means experiment records need to capture much more than final response values. Raw-material identity, batch, processing conditions, equipment settings, environmental conditions and analytical metadata can all become important parts of the learning system.

A Self-Driving Laboratory Does Not Need to Be Fully Autonomous on Day One

The image most people associate with a self-driving laboratory is a room filled with robotic arms.

That is only one possible endpoint.

A company can introduce autonomous decision-making before automating every physical task. Scientists may still prepare formulations manually while an optimization algorithm recommends the next experiments. Analytical results can then be entered automatically or manually before the model generates another recommendation.

This human-in-the-loop configuration often provides a more realistic starting point for formulation laboratories because existing instruments can continue to be used.

As the workflow matures, individual steps can gradually be automated: dispensing, mixing, curing, sample movement, testing or analytical interpretation.

The more useful question for an R&D manager is therefore not whether the organization can afford an entire robotic laboratory. It is which part of the experimental loop currently creates the greatest delay or decision bottleneck.

Self-Driving R&D Is Ultimately About Learning Faster

Speed is often presented as the primary advantage of laboratory automation, but running experiments faster is not necessarily the same as developing better materials faster.

A laboratory could double experimental throughput and still spend most of its effort testing low-value combinations.

The deeper value of autonomous experimentation comes from improving the relationship between each experiment and the next decision.

If an AI-guided workflow can determine that experiment 17 provides more useful information than experiments 17 through 40 of a conventional test matrix, the advantage does not come from robotics alone. It comes from using experimental resources more intelligently.

That distinction is particularly important for industrial formulation programmes where experiments may consume expensive specialty ingredients, analytical capacity and weeks of stability or durability testing.

The future self-driving laboratory is therefore unlikely to be defined simply by how many robots it contains. Its value will depend on how effectively experimental design, laboratory execution, analytics and scientific decision-making are connected.

Moving From AI Assistance to Agentic Chemical R&D

Chemical companies do not need to wait for a completely autonomous laboratory before beginning this transition.

The practical starting point is understanding which decisions can be supported by AI, which experimental variables should be optimized, what data need to be captured, where Bayesian optimization or active learning can add value, which laboratory steps are realistic candidates for automation and where human scientific judgement should remain mandatory.

The OnlyTRAININGS advanced session Agentic AI in Chemical R&D: Self-Driving Labs & Formulation Optimization is designed around this progression.

The training examines AI agents for chemistry, Bayesian optimization, active learning, formulation optimization, experimental feedback, laboratory automation, closed-loop workflows, data quality, failed experiments, human oversight and practical routes toward increasingly autonomous R&D.

It is intended for chemical and materials scientists who want to move beyond using AI merely to generate answers and begin understanding how AI can participate in experimental decisions.

Explore the Agentic AI in Chemical R&D training:
https://www.onlytrainings.com/course/agentic-ai-chemical-rd-self-driving-labs-formulation-optimization/

self-driving laboratories, agentic AI chemical R&D, autonomous experimentation, AI agents for chemistry, laboratory automation, closed-loop optimization, materials discovery, AI-driven experimentation, autonomous laboratory, chemical R&D automation, how self-driving laboratories work, agentic AI for chemical R&D, autonomous experimentation in chemistry, AI agents for chemistry and materials science, closed-loop experimentation chemical R&D, self-driving labs for formulation optimization


Read more →
How BASF is Advancing Responsible Sourcing
How BASF is Advancing Responsible Sourcing

Responsible sourcing is no longer limited to choosing a supplier with the right certificate.

For a global chemical company, it now involves tracing raw materials back through complex supply networks, examining environmental and human-rights risks, supporting suppliers that need to improve and determining whether renewable or circular alternatives can be introduced without disrupting production.

BASF’s latest responsible-sourcing activities show how this transition is taking shape across palm oil, coconut oil, castor oil and circular chemical feedstocks.

The company’s approach also demonstrates something procurement teams across the chemical industry are increasingly discovering: sustainability cannot be managed as a separate reporting exercise. It must be built into supplier selection, purchasing conditions, risk assessments, technical decisions and long-term supply relationships.

Traceability Comes Before Improvement

A company cannot properly manage a raw-material risk when it cannot identify where that material originated.

This is particularly important for palm oil and palm kernel oil. These renewable raw materials are widely used to manufacture ingredients for personal care products, detergents, cleaning formulations and other chemical applications. Their supply chains can extend from small agricultural producers to mills, processors, traders and chemical manufacturers.

In 2025, BASF traced 97.7% of its palm-based raw-material volume back to the oil-mill level. The company describes this level of visibility as an important contribution to supply-chain transparency and risk management.

Traceability does not automatically prove that every stage of the supply chain is sustainable. It does, however, give procurement teams a clearer foundation for identifying high-risk locations, examining sourcing practices and engaging suppliers where problems are found.

Without that visibility, sustainability commitments remain difficult to verify.

Certification Progress Has Not Followed a Straight Line

BASF’s 2025 results also reveal the practical difficulty of meeting responsible-sourcing targets when certified raw materials are not available in sufficient quantities.

The company reported that 79.2% of the palm oil and palm kernel oil it purchased during 2025 came from certified sources. That was significantly below the 98.1% recorded in 2024.

BASF attributed the reduction partly to limited availability of Roundtable on Sustainable Palm Oil-certified palm kernel oil. The company also said that the implementation of the EU Deforestation Regulation had contributed to shortages of materials suitable for the European market.

Rather than abandoning its commitment, BASF says it intends to continue increasing certified volumes where commercially and technically possible. RSPO certification remains its preferred standard.

The company has also moved its target for sourcing fully certified key palm derivatives to 2030. Those derivatives present an additional challenge because the palm material may have passed through several processing and transformation stages before entering a chemical formulation.

This is a useful reality check for the wider industry.

Responsible sourcing targets are necessary, but they cannot be achieved through procurement policy alone. Availability, regional regulation, supplier capability, segregation systems, certification capacity and commercial viability all influence whether a company can obtain compliant material at the required scale.

Responsible Sourcing Extends Beyond Palm Oil

BASF’s Care Chemicals business also uses other renewable oils, including coconut and castor oil, in products for cosmetics, personal care, detergents and industrial applications.

Each raw material presents a different set of sourcing risks.

Coconut supply chains often involve smallholders and geographically fragmented production. Responsible sourcing therefore requires more than checking the country of origin. It may involve certification, agricultural practices, working conditions and the economic resilience of farming communities.

Castor oil presents another distinct challenge.

India is central to the global supply of castor beans, while the oil itself is used across plastics, coatings, cosmetics, pharmaceuticals and several specialty chemical applications. BASF has participated in the Sustainable Castor Initiative, known as Project Pragati, since 2016.

The initiative brings BASF together with Arkema, Jayant Agro-Organics and the civil-society organisation Solidaridad. Its purpose is to address social, environmental, health and safety risks associated with castor cultivation.

Participating farmers receive training in areas such as:

  • Safer use of crop-protection products

  • Improved agricultural and cultivation practices

  • Soil protection and crop management

  • Occupational health and field safety

  • Personal protective equipment

  • Social and labour-related expectations

The work contributed to the development of SuCCESS, or Sustainable Castor Caring for Environment and Social Standards. The independently auditable framework covers 11 principles related to responsible castor production.

This approach goes beyond demanding compliance from farmers. It attempts to increase the capability of the supply chain to meet the required standard.

That difference matters.

A procurement system based only on supplier exclusion may remove an immediate risk from one company’s portfolio, but it does not necessarily improve conditions at the source. Supplier development, technical support and farmer training can create a more durable improvement.

Supplier Expectations Must Be Built Into Procurement

BASF’s wider procurement model requires suppliers to comply with applicable laws and internationally recognised environmental, social and governance standards.

Its Supplier Code of Conduct covers areas including:

  • Environmental protection

  • Human and labour rights

  • Child and forced labour

  • Occupational and social standards

  • Anti-discrimination

  • Anti-corruption

  • Expectations for subcontractors and upstream suppliers

BASF states that suppliers are evaluated on more than price and commercial performance. The company also examines environmental, social and governance factors and expects suppliers to promote similar principles within their own supply chains.

The company uses a risk-based approach rather than treating every supplier identically. Country risk, industry risk, material criticality and BASF’s ability to influence the supplier can all affect the level of scrutiny applied.

Evaluations are conducted through mechanisms including EcoVadis assessments, Together for Sustainability audits and selected Responsible Care audits. When weaknesses are identified, corrective-action plans and follow-up reviews are used to track improvement.

In 2025, BASF reported that 100 sustainability audits were conducted at raw-material supplier sites on its behalf. It also received EcoVadis assessments for 257 suppliers considered to have potential sustainability risks.

The model combines four elements:

Define the expectation. Suppliers need clear environmental, ethical and social requirements.

Identify the risk. Procurement teams must know which materials, countries and suppliers require greater attention.

Verify performance. Questionnaires alone may be insufficient where the exposure is significant.

Correct or escalate. Findings must lead to improvement plans, commercial consequences or, in serious cases, termination of the relationship.

Collaboration Can Reduce Repeated Supplier Assessments

BASF is also a founding member of Together for Sustainability, an initiative created by chemical companies to improve and standardise sustainability assessments across the industry.

Under the model, suppliers can be assessed using a shared framework rather than repeatedly completing different questionnaires and audits for every customer. Participating procurement teams can use recognised assessment information through a common system.

This offers two potential benefits.

First, it reduces duplicated work for suppliers serving multiple chemical companies.

Second, it creates greater consistency in how environmental, social, labour and governance performance is evaluated.

For responsible sourcing to scale across the chemical industry, this type of shared infrastructure may be essential. Thousands of suppliers cannot practically respond to entirely different assessment methods, evidence requests and audit expectations from every customer.

Standardisation does not remove the need for company-specific due diligence, but it can make the underlying process more efficient.

Circular Feedstocks Are Becoming a Sourcing Decision

Responsible sourcing is also beginning to influence the type of carbon and feedstock entering chemical manufacturing.

In 2024, BASF and Encina Development Group announced a long-term agreement for the supply of circular benzene produced from post-consumer plastic waste. BASF intends to use the chemically recycled material within its Ccycled product portfolio.

This expands the procurement question beyond whether a conventional feedstock was sourced responsibly.

Companies must now also consider:

  • Whether recycled or renewable feedstocks are available

  • How their origin and chain of custody will be verified

  • Whether the material meets process and purity requirements

  • How circular content will be allocated and documented

  • Whether supply is sufficient for commercial production

  • How sustainability claims will be supported

Circular sourcing therefore requires close coordination among procurement, R&D, production, quality, sustainability and regulatory teams.

A material may appear attractive from a sustainability perspective but still require extensive technical qualification before it can enter a chemical process. Similarly, a technically suitable material may not support a defensible sustainability claim if its sourcing and allocation records are inadequate.

Procurement Partnerships Can Enable Lower-Carbon Production

BASF’s work with Siemens Energy provides another example of procurement supporting a wider production transition.

In March 2025, BASF commissioned a 54-megawatt proton-exchange-membrane water electrolyser at its Ludwigshafen site. The system was built in cooperation with Siemens Energy and has an annual production capacity of up to 8,000 metric tonnes of hydrogen.

The electrolyser is integrated directly into the site’s chemical-production infrastructure. Hydrogen produced using renewable electricity can be supplied through the existing hydrogen network and used as a raw material for chemical products with a reduced carbon footprint.

BASF estimates that the project has the potential to reduce greenhouse-gas emissions at the Ludwigshafen site by up to 72,000 metric tonnes annually.

Although this is a manufacturing project, it also illustrates the strategic role of sourcing and supplier collaboration.

The transition to lower-carbon chemicals depends not only on laboratory innovation. It requires companies to procure new technologies, secure alternative energy and feedstock inputs, establish qualified partnerships and integrate them into existing production systems without compromising continuity.

What Other Chemical Companies Can Learn

BASF’s approach does not suggest that responsible sourcing has become simple or that every target has been achieved.

Its 2025 palm-certification result shows the opposite. Even a large global organisation can face shortages, regulatory complications and limited availability of materials that meet the preferred sustainability standard.

The more important lesson lies in how responsible sourcing is being managed.

It is increasingly treated as a continuous operating system built around:

  • Supply-chain traceability

  • Material-specific sourcing policies

  • Supplier codes and contractual expectations

  • Risk-based assessments and audits

  • Corrective-action management

  • Smallholder and supplier development

  • Cross-industry assessment frameworks

  • Circular and renewable feedstock qualification

  • Collaboration between procurement and technical teams

For chemical companies, the challenge is no longer deciding whether sustainability belongs in procurement.

The challenge is converting broad commitments into repeatable sourcing decisions that can survive technical review, supplier disruption, regulatory scrutiny and commercial pressure.

Turn Industry Developments Into Better Technical Decisions

Responsible sourcing, circular feedstocks and supply-chain transparency are changing how chemical companies select materials, qualify suppliers, manage compliance and plan future products.

Keeping up with these developments is useful. Knowing how to apply them within R&D, procurement, regulatory, quality and manufacturing decisions is what creates business value.

OnlyTRAININGS provides expert-led technical training for professionals across the chemical and allied industries. Its training portfolio covers sustainability and green chemistry, formulation, materials, regulatory compliance, processing, industrial problem-solving, artificial intelligence and emerging technologies.

Whether your team is responding to new sourcing requirements, evaluating alternative raw materials, strengthening regulatory capability or preparing for the next shift in chemical manufacturing, the platform is designed to help turn industry knowledge into practical action.

The Chemical Industry Is Changing. Is Your Team Keeping Up?

Explore Expert-Led Chemical Industry Trainings at OnlyTRAININGS

BASF responsible sourcing, sustainable procurement, responsible sourcing, chemical supply chain, supplier sustainability, sustainable sourcing, green procurement, supply chain sustainability, ethical sourcing, circular feedstocks, sustainable raw materials, supplier audits, supplier compliance, palm oil sourcing, castor oil sustainability, renewable raw materials, chemical procurement, ESG procurement, supply chain traceability, Together for Sustainability, circular economy chemicals, low-carbon chemicals, sustainable suppliers, procurement transformation, how BASF is advancing responsible sourcing, BASF sustainable procurement strategy, responsible sourcing in the chemical industry, how chemical companies manage responsible sourcing, BASF supplier sustainability requirements, sustainable sourcing of chemical raw materials, green procurement strategies for chemical companies, sustainability in chemical industry supply chains, ethical sourcing practices in the chemical industry, how BASF uses circular chemical feedstocks, sustainable raw material sourcing strategies, supplier sustainability audits in the chemical industry, BASF Supplier Code of Conduct requirements, BASF sustainable palm oil sourcing strategy, BASF sustainable castor oil sourcing initiative, responsible sourcing of renewable raw materials, sustainable procurement practices for chemical companies, ESG requirements for chemical industry suppliers, raw material traceability in chemical supply chains, BASF Together for Sustainability supplier programme, circular economy sourcing in chemical manufacturing, procurement strategies for lower-carbon chemical production, how to evaluate sustainable chemical suppliers, how sustainability is transforming chemical procurement


Read more →
Global Food Contact Material Compliance: How US, EU, and China Regulations Actually Differ
Global Food Contact Material Compliance: How US, EU, and China Regulations Actually Differ

If you manufacture or supply food contact materials for more than one market, you already know the frustrating truth: passing FDA review doesn't mean you're compliant in the EU, and EU compliance doesn't carry over to China. Each system evaluates safety differently, uses different documentation, and fails materials for different reasons.

This isn't a regulatory footnote. It's the single biggest reason multi-region product launches get delayed — not because the material is unsafe, but because a team optimized for one region's logic runs into another region's blind spot.

Here's how the three major systems actually compare, and where the real compliance risk sits in each one.

The Three Systems at a Glance

United States (FDA)European UnionChina
Core framework21 CFR Parts 170–199; FCN, GRAS, Prior Sanction, TOR pathwaysRegulation (EU) 10/2011 (plastics) + Framework Regulation 1935/2004GB 4806 series + GB 9685 (additives)
Approval modelPositive list + notification/petition systemPositive list ("Union list") + mandatory self-declaration (DoC)Positive list, material-specific GB standards
Who verifies complianceFDA reviews FCN submissions; GRAS can be self-determinedManufacturer self-declares via Declaration of ComplianceManufacturer declares compliance against GB standard; DoC required
Primary technical riskMigration/exposure thresholds, correct pathway selectionOverall migration limits, specific migration limits, NIAS assessmentMigration limits per material-specific GB standard, positive list matching
Recent regulatory activityFSMA supplier verification expectations continue to tightenRegulation (EU) 2026/245 (Feb 2026) expanded the authorized substances list; BPA rules under 2024/3190 tightened significantlyGB 4806.10-2025 (coatings) and GB 4806.16-2025 (silicone rubber) take effect September 2026, with BPA migration limits cut tenfold

United States: A Pathway Problem, Not a Listing Problem

Most teams assume FDA compliance is about checking whether a substance appears on a list. In practice, the harder decision is choosing the right pathway — Food Contact Notification (FCN), GRAS, Prior Sanction, or Threshold of Regulation (TOR) exemption — and defending that choice if it's challenged.

Each pathway carries different assumptions about migration, different timelines, and different levels of regulatory scrutiny. Choosing the wrong one, or leaning on an exemption that doesn't actually apply to the use case, is one of the most common causes of late-stage compliance failures — often after testing is already complete.

See the full FDA compliance framework, including FCN vs. GRAS decision logic →

European Union: Self-Declaration Puts the Burden on You

Unlike the US notification model, the EU runs on self-declaration. There's no "EU approval" — manufacturers must produce a Declaration of Compliance (DoC) demonstrating that a material meets Regulation (EU) 10/2011 (for plastics) and the broader Framework Regulation 1935/2004.

The EU's positive list (the "Union list" in Annex I) is under continuous revision — Commission Regulation (EU) 2026/245, which entered into force in February 2026, added and revised authorizations for several substances used in polyolefins, polyamides, PET, PLA, and PVC materials. Bisphenol A rules have also tightened substantially under Regulation (EU) 2024/3190, with transitional provisions running through September 2026 for products already on the market.

The technical risk that trips up most non-EU manufacturers isn't the positive list itself — it's Non-Intentionally Added Substances (NIAS): breakdown products, impurities, and reaction by-products that aren't deliberately added but still have to be risk-assessed. NIAS evaluation is where "compliant on paper" and "compliant in practice" most often diverge.

China: Fast-Moving Standards, Material-Specific Rules

China's GB 4806 series governs food contact materials by material type — separate standards exist for plastics, coatings, rubber, silicone rubber, paper, adhesives, and more, each with its own positive list under GB 9685.

This system has moved quickly in the past two years. Revised standards for coatings (GB 4806.10-2025) and silicone rubber (GB 4806.16-2025) take effect September 2026, expanding the approved substance list for coatings from 105 to 346 entries and cutting the BPA specific migration limit tenfold, from 0.6 mg/kg to 0.05 mg/kg. A draft standard for food-contact regenerated cellulose materials was also opened for consultation in 2026.

For international manufacturers, the practical risk in China isn't unfamiliarity with the concept of a positive list — it's the pace of standard revisions and the requirement to track which GB standard version applies to a specific material category, since older versions are explicitly invalidated once revisions take effect.

Why This Matters for Multi-Region Launches

The teams that get burned aren't the ones who don't know the regulations exist — they're the ones who apply one region's compliance logic to another region's system. FDA's notification model, the EU's self-declaration burden, and China's material-specific GB standards each require a different verification approach, different documentation, and different technical justification.

Getting this right up front — before formulation is locked and before submission timelines are set — is what separates a smooth multi-region launch from a late-stage scramble.

Go Deeper

This overview is intentionally high-level. For a full, decision-focused breakdown of FDA compliance specifically — including FCN vs. GRAS vs. Prior Sanction decision criteria, migration and exposure assessment logic, and the functional barrier assumptions that most often fail under review — see the complete training:

FDA Compliance for Food Contact Materials: Migration Risk, FCN/GRAS & Informed Compliance Decisions →


Sources: European Commission Food Safety Directorate; UL Solutions; SGS Safeguards; knoell regulatory updates; SESEC; ChemLinked; Kelley Drye & Warren (KHLaw) regulatory analysis.

Read more →